Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)

Phase Distribution

Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Terminated1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (100.0%)

Trials by Status

terminated133%
recruiting133%
active_not_recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruitingphase_2

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

NCT03624660
recruiting

High Resolution Anuscopy Study

NCT06697964
terminated

Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study

NCT02369497

Clinical Trials (3)

Showing 3 of 3 trials
NCT03624660Phase 2

Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer

Active Not Recruiting
NCT06697964

High Resolution Anuscopy Study

Recruiting
NCT02369497

Ascension® Humeral Resurfacing Arthroplasty (HRA) Follow-Up Study

Terminated

All 3 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
3